Top Markets
#1 Cortex Cortex +173.81%
#2 Helium Helium +65.43%
#3 GEKKO GEKKO +49.63%
#4 Pons Pons +21.47%
#5 ADO Protocol ADO Protocol +18.04%
#6 o1.exchange o1.exchange +14.04%
#7 龙虾 (Lobster) 龙虾 (Lobster) +12.45%
#8 Collect on Fanable Collect on Fanable +11.49%
#9 Siren Siren +11.09%
#10 Status Status +11.01%
Coin of the day
Cortex Cortex
Settings
Language
ENGLISH
Currency
USD
Theme
Paragon 28, Inc. Paragon 28, Inc.

Paragon 28, Inc.

FNA
Rank in Stocks #9071
Paragon 28, Inc. is a medical device company specializing in the development,... Paragon 28, Inc. is a medical device company specializing in the development, manufacturing, and global distribution of advanced surgical systems tailored for foot and ankle procedures. Its comprehensive product portfolio encompasses a wide array of solutions: Plating Systems: This includes the Gorilla plating series, offering specific solutions for Lisfranc injuries, Lapidus procedures, lateral column corrections, calcaneus slides, and naviculocuneiform (NC) fusions. Complementary products like Baby Gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates, as well as Silverback plating systems, are also available. Precision Guidance Technology: The company provides sophisticated guidance systems to enhance accuracy in various operations, such as fusion procedures for bunion deformities, first tarsometatarsal arthrodesis, metatarsal osteotomy for bunion correction, medial column beaming for Charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. Screw Systems: Paragon 28 offers robust screw systems, including the Monster, Mini Monster, and Joust beaming lines, which are critical for applications like bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, and fracture repair. Joint Replacement Solutions: Their offerings extend to total ankle replacement with the APEX 3D systems, alongside total talus spacers designed to replace the talus bone that links the leg and foot. Bunion/Hallux Valgus Correction Systems: Specifically for bunion management, the company provides nail systems such as the Phantom intramedullary nail systems, targeting severe hallux valgus cases. Orthobiologics: A substantial part of their product line comprises various orthobiologics, including bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix. They also feature PRESERVE bone graft systems for homologous applications. Ancillary Products: The company further supplies soft tissue fixation systems, titanium sprayed polyetheretherketone (PEEK) implants, nitinol staple systems, stabilization solutions, and specialized curved instruments. Paragon 28 distributes its products to hospitals and ambulatory surgery centers through an established network of both direct sales representatives and stocking distributors. Founded in 2010, the company maintains its corporate headquarters in Englewood, Colorado.
Share Price
$13.09
Last synced: 2025-04-17
Market Cap
$1.10B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Paragon 28, Inc. (FNA)

Category

Healthcare
P/E ratio for Paragon 28, Inc. (FNA)
P/E ratio as of August 2026 TTM: -19.83
According to Paragon 28, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -19.83. At the end of 2023 the company had a P/E ratio of -17.73.
P/E ratio history for Paragon 28, Inc. from 2019 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -19.83 25.93%
2024 -15.75 -11.19%
2023 -17.73 -18.61%
2022 -21.79 -77.94%
2021 -98.76 -118.56%
2020 532.01 109.94%
2019 253.41 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -280.38%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -275.78%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -207.84%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -205.37%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.